Medi Assist Healthcare IPO: What GMP signals ahead of listing tomorrow

If the current trends are sustained, the company's shares are expected to list with a premium of 8%. The issue was priced in the range of Rs 397-418.

Agencies
The shares of Medi Assist Healthcare will debut on the exchanges on Tuesday, January 23. Ahead of the listing, the company's shares are trading with a premium of Rs 32-36 in the unlisted market.

If the current trends are sustained, the company's shares are expected to list at a premium of 8%. The issue was priced in the range of Rs 397-418.

However, it is important to note that grey market premiums are just an indicator as to how the company's shares are stacked up in the unlisted market and are subject to change rapidly.


Medi Assist Healthcare IPO subscription

The public offer of Medi Assist Healthcare was subscribed 16 times at close, led by strong demand from institutional investors, whose category was subscribed 40 times.

Medi Assist will not receive any funds from the IPO since it is completely an OFS and the entire proceeds will go to the selling shareholders.

Also Read | Nova Agritech, Epack Durable IPOs deferred by a day; Medi Assist listing postponed
ADVERTISEMENT

Medi Assist Healthcare IPO review

Analysts believe the IPO offered investors an opportunity to invest in a leading third-party administrator (TPA) health-tech and insurance-tech company.

On valuation parse, at the upper band, the issue was asking for a market cap of Rs 2,878 crore.

About Medi Assist

Medi Assist is a health and insurance tech company that manages health benefits for employers, individual members and public systems that primarily serve insurance companies. Founded in 2002, the company acts as an intermediary between insurers, and healthcare operators, providing health insurance and cash insurance across more than 14,000 hospitals in India.

The company offers services to 78% of the Nifty 50 companies and 35% of the BSE500 companies.
ADVERTISEMENT

Medi Assist Healthcare Financials

For the six months ended September 2023, the company's total income rose 26% year-on-year to Rs 312 crore, while net profit fell 39% to Rs 22.5 crore.

Axis Capital, IIFL Securities, Nuvama Wealth Management, and SBI Capital Markets are the book-running lead managers to the issue.
ADVERTISEMENT

(You can now subscribe to our ETMarkets WhatsApp channel)

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)
ADVERTISEMENT
READ MORE

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

More from our Partners

Loading next story
Business News › Markets › IPOs/FPOs › Medi Assist Healthcare IPO: What GMP signals ahead of listing tomorrow
Text Size:AAA
Success
This article has been saved

*

+